
Migace 150mg Injection
Marketer
Novalab Healthcare Pvt Ltd
Salt Composition
Aceclofenac (150mg)
Overview Migace 150mg Injection
ArthroCare 150mg Injection provides analgesic relief. This injectable medication effectively manages pain and inflammation associated with conditions such as rheumatoid arthritis, ankylosing spondylitis, and osteoarthritis, offering pain relief for joints and muscles when oral medication isn't feasible. Administration must be performed by a qualified medical professional; self-injection is strictly prohibited. Patients with a history of cardiovascular events (heart disease or stroke) should inform their physician before use. Report any injection site reactions (pain, swelling, redness) to your doctor immediately. Potential side effects include nausea, vomiting, abdominal discomfort, and indigestion. Dizziness, drowsiness, and blurred vision are also possible. For prolonged therapy, regular monitoring of kidney and liver function, as well as blood counts, may be necessary. Extended use carries a risk of serious complications, including gastrointestinal bleeding and renal impairment.
Uses of Migace 150mg Injection
Analgesia
Major Benefits of Migace 150mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Migace 150mg Injection:
- Vomiting
- Stomach pain/epigastric pain
- Nausea
- Indigestion
- Diarrhea
- Injection site reactions (pain, swelling, redness)
- Heartburn
- Loss of appetite
How to use Migace 150mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Migace 150mg Injection works:
Migace 150mg Injection, a non-steroidal anti-inflammatory drug (NSAID), inhibits the production of inflammatory mediators responsible for pain and the associated redness and swelling.
SAFETY ADVICE
AlcoholCAUTION
Use of alcohol with Migace 150mg Injection requires careful consideration. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
The use of Migace 150mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against potential hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Migace 150mg Injection with breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
The administration of Migace 150mg Injection can potentially reduce attentiveness, impair vision, and induce drowsiness or dizziness. Driving should be avoided if such effects manifest.
KidneyCAUTION
For individuals with impaired kidney function, Migace 150mg Injection requires careful administration and potential dosage modification. Patients with severely compromised kidneys should avoid Migace 150mg Injection. Physician consultation is advised.
LiverCAUTION
For individuals with liver impairment, Migace 150mg Injection requires careful administration, potentially necessitating dosage modification. Physician consultation is recommended. Migace 150mg Injection is contraindicated in patients exhibiting severe hepatic dysfunction. Consistent monitoring of liver function is advised during treatment.
What if you forget to take Migace 150mg Injection :
Omit a Migace 150mg Injection? Seek medical advice.
Facts to Know About Migace 150mg Injection
| Label | Value |
|---|---|
| Chemical Classification | Dichlorobenzene derivative |
| Developing Habits | No. |
| Treatment Category | Pain Relievers |
| Behavior Class | Non-selective COX-1 and COX-2 inhibitors (acetic acid derivatives) |
